drugset

drugset / Trial / NCT07367529

A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection

NCT07367529 ↗

Phase 1/2 Recruiting 465 enrolled Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

NaSingle-groupOpen-labelTreatment

Summary

To evaluate the efficacy and safety of TQB6411 for Injection in subjects with advanced lung cancer

Timeline

Start: 2026-02-26
Primary completion: 2028-12
Completion: 2028-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	TQB6411	Other / unclassified	—	—

Indications